Federal Circuit Dismisses Patent Appeal For Lack Of Standing
WASHINGTON, D.C. — Novartis prevailed April 23 when the Federal Circuit U.S. Court of Appeals found that a dissatisfied inter partes review (IPR) petitioner lacks standing to appeal a final written...To view the full article, register now.
Already a subscriber? Click here to view full article